Characterization of the ORL1 receptor on adrenergic nerves in the rat anococcygeus muscle

Citation
M. Ho et al., Characterization of the ORL1 receptor on adrenergic nerves in the rat anococcygeus muscle, BR J PHARM, 131(2), 2000, pp. 349-355
Citations number
44
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
131
Issue
2
Year of publication
2000
Pages
349 - 355
Database
ISI
SICI code
0007-1188(200009)131:2<349:COTORO>2.0.ZU;2-L
Abstract
1 Nociceptin, the endogenous ORL1 receptor agonist inhibited the motor resp onse to electrical-field stimulation in the rat anococcygeus muscle. This e ffect was characterized using the peptide ligands acetyl-Arg-Tyr-Tyr-Arg-Tr p-Lys-NH2 (Ac-RWRWK-NH2), acetyl-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 (Ac-RYYRIK-NH2 ) and [Phe(1)psi(CH2-NH)Gly(2)]nociceptin(1-13)NH2 ([F/G]NC(1-13)NH2), and the non-selective opioid antagonist naloxone benzoylhydrazone (NalBzOH). 2 Nociceptin produced a concentration-dependent inhibition of the adrenergi c motor response to electrical-field stimulation (EC50 19 nM, pEC(50) 7.7 /- 0.1, n = 8), but the response to exogenous noradrenaline (0.2-1 mu M) wa s unaffected. The inhibitory nerve response was not affected by up to 1 mu M nociceptin. 3 After inhibition of nitric oxide synthase (N-omega-nitro-L-arginine 100 m u M), and in the presence of peptidase inhibitors, nociceptin produced full inhibition of the pure adrenergic motor response (EC50 4 nM; pEC(50) 8.4 /- 0.1, E-max 98.3 +/- 1.2%, n = 12). Ac-RYYRWK-NH2 was a potent partial-ag onist (pEC(50) 9.0 0.1, E-max 66.4 +/- 5.2; n = 11) but the efficacy of Ac- RYYRIK-NH2 (EC50 8.0 +/- 0.2, E-max 36.7 +/- 3.5; n = 12) was lower and the peptide could be tested as an antagonist (pA(2) 9.01). 4 [F/G]NC(1-13)NH2 and NalBzOH had little or no efficacy and were competiti ve antagonists with pKB values of 7.4 (95% c.l. 7.1, 7.7) and 6.9 (95% c.l. 6.7, 7.1) respectively. Both increased the response to field stimulation a t high concentrations, suggesting the release of an endogenous agonist for the ORL1, receptor during stimulation. 5 Rat nocistatin did not affect the response to electrical-held stimulation , nor did it modify the inhibitory action of nociceptin. 6 Our findings suggest there is a significant endowment of ORL1, receptors on sympathetic terminals of the rat anococcygeus, where nociceptin mediates a powerful inhibitory effect on adrenergic neuromuscular transmission.